NM_080860.4:c.450C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_080860.4(RSPH1):​c.450C>T​(p.Ala150Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,614,138 control chromosomes in the GnomAD database, including 116 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0060 ( 10 hom., cov: 33)
Exomes 𝑓: 0.011 ( 106 hom. )

Consequence

RSPH1
NM_080860.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.859

Publications

2 publications found
Variant links:
Genes affected
RSPH1 (HGNC:12371): (radial spoke head component 1) This gene encodes a male meiotic metaphase chromosome-associated acidic protein. This gene is expressed in tissues with motile cilia or flagella, including the trachea, lungs, airway brushings, and testes. Mutations in this gene result in primary ciliary dyskinesia-24. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2014]
RSPH1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 24
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 21-42485720-G-A is Benign according to our data. Variant chr21-42485720-G-A is described in ClinVar as Benign. ClinVar VariationId is 241784.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.859 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00596 (908/152266) while in subpopulation NFE AF = 0.0105 (713/68022). AF 95% confidence interval is 0.00984. There are 10 homozygotes in GnomAd4. There are 437 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RSPH1NM_080860.4 linkc.450C>T p.Ala150Ala synonymous_variant Exon 5 of 9 ENST00000291536.8 NP_543136.1 Q8WYR4-1
RSPH1NM_001286506.2 linkc.336C>T p.Ala112Ala synonymous_variant Exon 4 of 8 NP_001273435.1 Q8WYR4-2
RSPH1XM_011529786.2 linkc.450C>T p.Ala150Ala synonymous_variant Exon 5 of 8 XP_011528088.1
RSPH1XM_005261208.3 linkc.243C>T p.Ala81Ala synonymous_variant Exon 3 of 7 XP_005261265.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RSPH1ENST00000291536.8 linkc.450C>T p.Ala150Ala synonymous_variant Exon 5 of 9 1 NM_080860.4 ENSP00000291536.3 Q8WYR4-1
RSPH1ENST00000398352.3 linkc.336C>T p.Ala112Ala synonymous_variant Exon 4 of 8 5 ENSP00000381395.3 Q8WYR4-2
RSPH1ENST00000493019.1 linkn.1076C>T non_coding_transcript_exon_variant Exon 4 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.00596
AC:
907
AN:
152148
Hom.:
10
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00205
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00801
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0105
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00605
AC:
1522
AN:
251486
AF XY:
0.00614
show subpopulations
Gnomad AFR exome
AF:
0.00191
Gnomad AMR exome
AF:
0.000954
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00850
Gnomad NFE exome
AF:
0.0108
Gnomad OTH exome
AF:
0.00587
GnomAD4 exome
AF:
0.0108
AC:
15717
AN:
1461872
Hom.:
106
Cov.:
30
AF XY:
0.0104
AC XY:
7535
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.00161
AC:
54
AN:
33480
American (AMR)
AF:
0.00107
AC:
48
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000556
AC:
48
AN:
86258
European-Finnish (FIN)
AF:
0.00910
AC:
486
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0132
AC:
14651
AN:
1111992
Other (OTH)
AF:
0.00707
AC:
427
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
794
1588
2382
3176
3970
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
546
1092
1638
2184
2730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00596
AC:
908
AN:
152266
Hom.:
10
Cov.:
33
AF XY:
0.00587
AC XY:
437
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.00205
AC:
85
AN:
41562
American (AMR)
AF:
0.00124
AC:
19
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4818
European-Finnish (FIN)
AF:
0.00801
AC:
85
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0105
AC:
713
AN:
68022
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
44
89
133
178
222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00980
Hom.:
4
Bravo
AF:
0.00537
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0105
EpiControl
AF:
0.00907

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RSPH1: BP4, BP7, BS1, BS2 -

Primary ciliary dyskinesia 24 Benign:1
Apr 04, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
2.1
DANN
Benign
0.66
PhyloP100
-0.86
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117797631; hg19: chr21-43905830; COSMIC: COSV52321865; API